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Abstract.  Amphiregulin (AR) is a newly discovered 
glycosylated, 84-arnino acid residue polypeptide 
growth regulator which has sequence homology to the 
EGF family of proteins. To obtain immunological re- 
agents to study the biological role of AR, two syn- 
thetic peptides containing sequences corresponding to 
distinct regions of AR were used to generate poly- 
clonal antibodies in rabbits.  One preparation of an- 
tipeptide antibodies directed against residues 26-44 of 
AR (AR-Ab2) was most effective in the detection of 
native AR, whereas another preparation of antibodies 
against residues 8-26 (AR-Abl)  was found to be most 
efficacious in the detection of AR in formalin-fixed 
and paraffin-embedded tissues. 
The growth of a colon carcinoma cell line, Geo, 
which proliferates autonomously under serum-free 
conditions, was stimulated by the exogenous addition 
of AR or EGE Half-maximal stimulation of this 
growth was observed at 40 and 200 pM of EGF and 
AR, respectively. A mAb to the extracellular domain 
of the EGF receptor blocked the stimulation of cell 
proliferation induced by the exogenous addition of 
AR, suggesting that this stimulation was mediated via 
the EGF receptor. Geo cells were found to constitu- 
tively express significant levels of the AR mRNA tran- 
script as determined by analysis of the polymerase 
chain reaction-amplified eDNA product and AR pro- 
tein was detected immunocytochemically using the 
AR-Abl antibodies in these cells. AR was immunopre- 
cipitated specifically using the AR-Ab2 antibodies 
from the conditioned medium of Geo cells, which had 
been metabolically labeled with [35S]cysteine. The 
secreted AR migrated as a broad band (18.5-22.5 kD) 
with a median molecular weight of ,x, 20.7 kD in SDS- 
PAGE. Immunospecific removal of AR from serum- 
free medium conditioned by the Geo cells and readdi- 
tion of the AR-depleted medium to Geo cells resulted 
in an ,'040%  inhibition of cell growth relative to con- 
trois. Furthermore, the growth of the Geo cells was 
also inhibited by ,,o50% by the addition of the anti- 
EGF receptor mAb alone. These results indicate that 
AR and the EGF receptor are involved in the auto- 
crine growth of these cells and suggests that AR may 
act through the EGF receptor via an extracellular au- 
tocrine loop. 
To study the expression of AR in human colon in 
vivo, AR was localized immunocytochemically in 
formalin-fixed, paraffin-embedded sections from nor- 
mal and malignant human colon using the ARoAbl  an- 
tibodies. In all normal colon specimens, AR was 
localized to the cytoplasm and nucleus of the termi- 
nally differentiated, non-proliferative surface columnar 
and secretory epithelial cells of the mucosa, but was 
not detectable in the proliferative epithelial cells of the 
crypts. In four out of five colonic carcinomas, AR was 
localized to the cytoplasm and/or nucleus of the cells. 
In conclusion, AR can act as an autoerine growth 
stimulator for colonic carcinoma cells in vitro and 
may perform a growth regulatory function in normal 
and rnalignant colon in vivo. 
T  HER~ is a rapidly growing number of EGF-like growth 
regulatory polypeptides  such as transforming growth 
factor ,v (TGFot)I (Todaro and DeLarco, 1978), am- 
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1. Abbreviations used in this paper: AFt, amphiregulin;  PCR, polymerase 
chain reaction;  TGFc~, transforming  growth factor c~. 
phiregulin  (AR) (Shoyab et al., 1988), cripto (Ciccodieola 
et al.,  1989), and heparin-binding  EGF-like growth factor 
(Higashiyama et al., 1991). With the exception of TGFct, lit- 
tle is known about the expression,  mechanism of action and 
role that these growth factors may play in normal biological 
and pathological processes. AR is a glycosylated, 84-amino 
acid residue polypeptide originally purified from the condi- 
tioned medium of the human breast carcinoma cell line, 
MCF-7, after treatment  with PMA (Shoyab et al., 1988). The 
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dues 44-84)  has 38 and 32%  sequence identity with EGF 
and TGFct, respectively (Shoyab et al., 1989). The very ba- 
sic, hydrophilic, NH2-terminal region of AR contains two 
putative nuclear targeting sequences positioned at residues 
26-29 and 40--43 (Shoyab et al., 1989) and AR has been de- 
tected in the nucleus of both normal and malignant ovarian 
epithelial cells (Johnson et al., 1991). The mature AR pro- 
tein is believed to be derived from the proteolytic cleavage 
of  a 252-amino acid residue transmembrane precursor (Plow- 
man et al.,  1990). 
AR can act to stimulate or inhibit the proliferation of cells 
depending on the concentration of AR and the nature of the 
target cell (Shoyab et al., 1988; Johnson et al., 1991). Unlike 
EGF  or  TGF~  AR  does  not  promote  the  anchorage- 
independent growth of normal rat kidney (NRK) fibroblasts 
in the presence of transforming growth factor-~ (Shoyab et 
al.,  1989).  Cultured human keratinocytes produce and re- 
spond to AR and the mitogenic activity of AR can be inhib- 
ited by heparin sulfate (Cook et al., 1991). AR can partially 
compete with 125I-EGF for binding to the EGF receptor on 
A431 cells, but has a lower affinity for the receptor than does 
EGF (Shoyab et al., 1989).  Many carcinoma cell lines and 
normal human tissues, including ovary, placenta, pancreas, 
cardiac muscle, testis, breast, lung, spleen, kidney, and co- 
lon, express the 1.4-kb AR mRNA transcript (Plowman et 
al., 1990). However, to date there is no available information 
regarding the localization of AR to specific cells of any nor- 
real tissue in vivo.  Recently, AR rnRNA has been detected 
in ,~66 % of primary or metastatic human colorectal carci- 
nomas (Ciardiello et al.,  1991b). 
The colonic mucosa is a constantly self-renewing layer of 
epithelial cells which proliferate, mature, differentiate, and 
are eventually shed (reviewed in Wright, 1989; and Colony, 
1989).  Regrettably, the maintenance of normal colonic epi- 
thelial cells in long-term culture has not been possible and 
thus, studies probing the potential role that growth factors 
play in colonic epithelial cell growth relies heavily upon the 
use of colonic carcinoma cells in vitro (Colony, 1989; MUl- 
der and Brattain, 1989).  There is considerable evidence to 
suggest that EGF-like factors play a role in the growth of nor- 
mal and malignant colonic epithelial cells. EGF has been 
shown to stimulate normal crypt cell proliferation in rats in 
vivo (Goodlad et al. 1987; Reeves et al., 1991) and Wright 
and co-workers (1990) have demonstrated that ulceration of 
the epithelium anywhere in the human gastrointestinal tract 
results in the induction of a novel EGF-secreting cell lineage 
that promotes ulcer healing. The EGF receptor has been de- 
tected in normal rat CKoyama and Podolsky, 1989) and hu- 
man  colonic  epithelium (Markowitz  et  al.,  1990).  EGF 
receptors are expressed at a high frequency in colon carci- 
nomas in vivo (Yasui et al., 1988;  Moorghen et al., 1990) 
and in cell lines derived from these carcinomas (Wan et al., 
1988;  Murthy et al.,  1989).  Further, TGFc~ mRNA and/or 
protein  has  been  detected  in  normal  colonic  epithelium 
(Markowitz et al., 1990; Cartlidge and Elder, 1989; Koyama 
and Pedolsky, 1989) as well as in colon carcinomas (Malden 
et al.,  1989;  Liu et al.,  1990). 
In the work reported here, we have used a colon carcinoma 
cell line to study the mechanism of AR action and its poten- 
tial role as an autocrine growth factor in vitro. We have also 
studied the expression and localization of AR in both normal 
and malignant human colon with the aim that the results will 
provide insight into the biological role that AR might play 
in vivo.  The results demonstrate for the first time that AR 
can function as an autocrine growth factor for a carcinoma 
cell line in vitro and suggest that the mitogenesis induced by 
AR is mediated by the EGF receptor. We have also localized 
AR in vivo to the terminally differentiated, non-proliferative 
epithelial cells of normal colonic mucosa, but not to the 
proliferative cells of  the crypts. Further, we demonstrate that 
AR can be detected immunocytochemieally in the nucleus 
as well as the cytoplasm of normal and malignant colonic ep- 
ithelial cells in vivo. 
Materials and Methods 
Cell Culture 
Geo human colon carcinoma cell line (Brattain et al., 1981) was generously 
provided by Dr.  M. Brattain (Baylor College of Medicine,  Houston, TX) 
and the MDA-MB-453 and MCF-7 human breast cancer cell lines were ac- 
quired from the American Type Culture Collection (Rockville, MD). Cells 
were grown at 37~  in a 5% CO2 atmosphere under serum-free conditions 
in  McCoys  5A  medium  containing 2  mM  L-glutamine,  0.1  mM  non- 
essential  amino acids, 25/~g/ml gantamicin (GIBCO BRL, Gaithersburg, 
MD) and 2% (vol/vol) PC-1 serum-free supplement (Ventrex Laboratories, 
Portland, ME) (serum-free  medium). 
Purification and Characterization of  Amphiregulin 
AR was purified to homogeneity from the conditioned medium of MCF-7 
cells which had been treated with PMA, and characterized as previously 
described (Sboyab et ai.,  1988,  1989). The purified AR was found to be 
homogeneous as determined by amino acid sequencing by Edman degrada- 
tion, SDS-PAGE, gel exclusion HPLC and analytical reversed phase HPLC. 
Generation and Characterization of  Antipeptide 
Antibodies against  Amphiregulin 
Cys-ARS"2~-NH2 and Cys-AR~"44-NH2 were synthesized  and purified un- 
der contract by Multiple Peptide Systems (San Diego, CA). The numbering 
of the amino acid residues  in AR is as described in Shoyab et al. (1989). 
The peptides were synthesized  by the method of Honghten (1985) and 
purified by preparative reverse phase HPLC. 20 mg of each peptide was then 
conjugated  through the side chain sulfhydryl to 16 mqg of keyhole limpet 
hemocyanin  using m-maieimidobenzoyl-N-hydroxysuccinimide  ester and 
each conjugate was used to immunize two rabbits (Harlow and Lane, 1988). 
Before immunization, the rabbits were bled to generate control preimmune 
serum. Antisera were screened for a response to the peptide antigen starting 
10 d after the first boost, as follows. 40 ng of the peptide in 50 ~1 of 0.1 
M NaHCO3, pH 9.1 was incubated in each well of an Immulun II ELISA 
plate (Dynatech Laboratories, Chantilly,  VA) for 16 h at 4~  The wells 
were then blocked with 3 % BSA in PBS for 2 h at ambient temperature. 
50 /~1 of various dilutions of preimmune and post-immune sera in 1% 
BSMPBS was added to each well and incubated for 2 h at ambient tempera- 
ture.  Bound IgG was detected  using biotinylated donkey anti-rabbit IgG, 
F(ab')2 fragment followed  by  streptavidin-aikaline phosphatase (Amer- 
sham Corp., Arlington Heights,  IL). Color development was performed 
using the phosphatase substrate system for ELISA (Kirkegaard  & Perry 
Laboratories, Inc., Gaithersborg, MD). Antisera were then screened for the 
ability to detect purified homogeneous AR in an ELISA format and to im- 
munoprecipitate specifically  [3SS]cysteine-labeled AR from medium con- 
ditioned by MCF-7  cells which bad been treated with PMA. The ELISA 
for AR was performed as described above by adhering various  quantities 
of purified AR to the bottom of an Immulon II ELISA plate and measuring 
the specific  response generated using sera dilutions at 1:1,000. Antisera 
were tested for the ability to immunoprecipitate AR as described in the sec- 
tion titled "Metabolic Labeling with [~SS]Cysteine and Immunoprecipita- 
tion of Secreted Amphiregulin7 The usefulness of these antibodies for the 
iramunocytochemical  detection of AR was  determined using cell lines 
which are known to be positive and negative for AR mRNA. The following 
cell lines were used:  MCF-7 before and after treatment with PMA (pusi- 
five), SK-OV-3 (positive) (Plowman et al., 1990), LS 174T (positive), YVC 
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chemistry was performed as described in the "Immunoeytnchemistry of 
Cultured Cells  ~ section. 
Purification of  Rabbit IgG 
Rabbit IgG was purified from control serum and antiserum using Immuno- 
pure Immobilized Protein A/G gel (Pierce Chemical Co., Rockford, IL) ex- 
actly as described by the manufacturer.  The purified IgG was  dialyzed 
against PBS using tubing with a  12-14 kD cutoff (GIBCO BRL). 
Mitogenesis Assay and Effect of  an Anti-EGF Receptor 
mAb on the Amphiregulin-induced Mitogenesis 
Mitogenesis assays were performed in serum-free medium (see "Cell Cul- 
ture" section) in 48-well plates. Cells were initially plated at a density of 
10,000 cells/well in 0.5 ml of serum-free medium and allowed to attach to 
the plate for 16 h. The medium was replaced with 0.4 ml of serum-free 
medium containing various concentrations of purified AR or EGF (GIBCO 
BRL). Each concentration of AR was assayed in triplicate and the control 
(no AR or EGF) was performed in six wells.  After 4 d at 370{2, the cells 
were trypsinized in 100 ~1 and cells were counted using a hemocytometer. 
To ascertain the effect of an anti-EGF receptor rnAb on the AR-induced 
mitogenesis,  cells were plated in 12-well plates at a density of 30,000 cells/ 
well and allowed to attach to the plate for 16 h. The next day the medium 
was changed to 0.98 rnl of serum-free medium containing either 10 nM of 
an anti-EGF receptor IgGl mAb (No. 05-101; Upstate Biotechnology, Inc., 
Lake Placid, NY) or 10 nM of an isotype IgGx control mAb (No.  1170252, 
Boehringer Mannheim Biochemicais, Indianapolis, IN). After 30 rain, 20 
~1 of I0 nM AR in serum-free medium was added to each well. 4 d later, 
cells were trypsinized, dispersed using a syringe with a 19-gauge needle and 
counted using a Coulter counter (Coulter Electronics Inc., Hialeah, FL). 
Removal of  Amphiregulin  from Medium Conditioned 
by Geo Cells Using Anti-AR Antibodies 
Cells were plated into 12-well plates at a density of 48,000 cells/well  and 
allowed to attach for 12 h. The next day (day 2), the medium was replaced 
with 1 mi of fresh serum-free medium and the cells were allowed to grow 
for an additional day. On day 3, the conditioned medium from each well 
was collected and 34 ~1 of either 1 ttg/ttl purified AR-Ab2 IgG or preim- 
mune IgG (control) in PBS was added to the conditioned medium. After 
a 45-rain incubation at ambient temperature, 17 p.l of Protein A ngarose 
(GIBCO BRL) was added and the mixture rocked for 45 rain. The processed 
conditioned medium was then separated from resin and sterilized using 
Spin-X centrifuge filter units (Costar, Cambridge, MA). This processed 
conditioned medium was added back to the appropriate wells of  the 12-well 
plate and the cells were allowed to continue growing. On day 4, processing 
of the conditioned medium was repeated.  On day 5, the cells were counted 
as described in the previous section. 
Growth of Cells in the Presence of  Anti-EGF 
Receptor mAb 
Cells were plated into 12-well plates in 1 ml of serum-free medium at a den- 
sity of 30,000 cells/well and allowed to attach to the plate overnite. The next 
day the medium was exchanged with serum-free medium containing either 
10 nM of the anti-EGF receptor mAb, 10 nM of the isotype IgG1 control 
mAb or no mAb. After 4 d, cells were counted. 
Isolation of Cellular RNA 
Isolation of total cellular RNA from cells was  accomplished using the 
method of Rappolee et al. (1988) with the following modifications. Approxi- 
mately 70% confluent cell monolayers  in 75 em  2 flasks were trypsinized, 
immediately centrifuged at 600 g for 5 rain and the resultant pellet lysed 
in 2.0 ml of 4 M guanidiuium thiocyanate, 25 mM Tris/HCl, 0.01 M 2-mer- 
captcethanol, 0.5%  (wt/vol) sodium sarcosine, pH 7.4. DNA was sheared 
by passing the lysates through a  19-gauge needle attached to a  lO-ee sy- 
ringe.  Lysates were layered onto a 2.7-mi cesium trifluoroacetate gradient 
(1.51 g/mi) (Pharmaeia Fine Chemicals, Piseataway, NJ) and resolved by 
ultracentrifugation at 125,000 g for 24 h at 15"C. The RNA pellet was dis- 
solved in RNase-free  1-120, digested  with RNase-free  DNase I  (1  U//~g 
RNA) (Promega, Madison, WI) for 30 rain at 37"C and extracted twice with 
phenol/chloroform/isoamyl alcohol (25:24:1).  RNA was precipitated with 
0.3 M sodium acetate and ethanol, vacuum dried, redissolved in RNase-free 
H20,  and the concentration and purity of the RNA (OD2~ nm/280  m) was 
determined. 
Reverse Transcription and Palymerase Chain Reaction 
cDNA was prepared using oligo(dT) primers with the RiboClone eDNA 
Synthesis  System (Promega)  according  to the modified method of Gubler 
and Hoffman (1983) using avian myeloblastosis  virus reverse transcriptase. 
The resulting eDNA samples (100 ng each) were co-amplified using 30 cy- 
cles of polymerase chain reaction (FCR) with sense and antisense primers 
as described by Saiki et al. (1988). Sense and antisense primers for AR cor- 
respond to positions 510-533 and 738-761 of the AR eDNA (Plowman et 
al.  1990),  respectively,  and  correspond  to  the  mature  protein coding 
regions.  The DNA thermal cycle profile consisted of l-rain denaturation 
step at 94"C, a 2-rain annealing step at 55"C, and a l-rain primer extension 
step at 72*C.  PCR products  were eleetrophoresed at constant voltage 
(100 V) on a 2% Seakem GTG, 0.5% Seakem ME agarose gel (FMC Bio- 
Products, Rockland, ME) containing Tris/acetate EDTA buffer (Quality Bi- 
ologicals,  Inc., Gaithersburg,  MD). 
Metabolic Labeling with [J~S]Cysteine and 
lmmunoprecipitation of  Secreted A mphiregulin 
Cells were grown to '~70% confluence in a 25-cm  2 flask.  The cells were 
washed  three times with MEM Select-Amine  medium (GIBCO) which 
lacked L-cysfine. 5 mi of the Select-Amine medium was added to the cells 
and incubated at 37"C. After 30 rain, 2.6 ml of the Select-Amine medium 
containing 0.8 mCi of [35S]cysteine was added to the cells. After 22 h, the 
conditioned medium was collected and placed on ice. Proteinase inhibitors 
(300x stock solutions) were added to yield final concentrations of 4 mM 
EDTA, I t~M pepstafin  A, 0.2  mM  PMSF, and I/~M leupoptin.  The pH 
of  the  solution  was  adjusted  to  pH 7.2  with  I  M  NaOH and centrifuged  at 
800 g. The supernatant was collected, 15 ~  of preimmune serum added 
and incubated  at 4"C for 60 rain. 75 t~l of  a protein A agarose resin (GIBCO) 
was added and the sample rocked for 60 rain at 4"C. The sample was cen- 
trifuged at 800 g, supernatant removed, and split into three equal aliquots. 
Each aliquot received either 5/~1  of preimmune serum,, 5/~1 of postimmune 
serum or 5/~1 of postimmune serum plus 20/tg of the paptide antigen. The 
samples were incubated at 4"C. After 60 rain, 25 t~l of the protein A agarose 
was added to each sample and rocked at 4"C for 60 rain. The samples were 
then centrifuged in a microfuge (Microfuge  12; Beckman Instruments, Inc., 
Palo Alto, CA) at 10,000 rpm for 2 min. The supernatant was discarded 
and the resins washed three times with 1 mi of 50 mM Tris, pH 7.5, contain- 
ing 0.05%  NP-40.  50 ~  of SDS-PAGE  sample buffer containing 2.5% 
2-mercaptoethanol was added to the resin and it was heated to 85~  for 10 
min. The samples were then run in a 16% acrylamide SDS-PAGE gel, fixed 
for 30 rain in 25%  isopropanol/lO%  acetic acid,  treated with Amplify 
fluorographic reagent (Amersham Corp.), and autoradiograpbed at -80"C. 
Immunocytochemistry of Cultured Cells and 
Formalin-fixed, Paraffin-embedded Sections 
Cultured cells were  plated into Lab-Tek-4  chamber slides (Nunc,  Inc., 
Naperville,  IL)  at  20,000  cells  per  chamber  and  grown  to  ,~,70% 
confluence.  The cells were washed twice with PBS and fixed with 1.5% 
formaldehyde in PBS for 45 rain at room temperature. The cells were then 
washed four times with PBS.  10% goat serum in PBS (0.5 ml) was then 
added to each chamber and incubated for 45 rain at room temperature.  This 
solution was aspirated and 0.5 mi of 10/zg/rnl preimmune (control) IgG or 
AR-Abl  IgG in 03% BSA/PBS was added. AR-Abl IgG that was preab- 
sorbed with peptide (1 ttg IgG per 1 t~g peptide) for 2 h at 37~  was also 
used at this step to confirm specificity. After a 1-h incubation at room tem- 
perature the cells were washed twice with PBS and bound lgG was detected 
using the Vectastain ABC kit for rabbit IgG (Vector Laboratories, Burlin- 
game,  CA).  Ceils were counterstained with Mayer's hematoxylln ('No. 
GHS-I-16, Sigma Chemical Co.,  St.  Louis,  MO)  for 2  rain and slides 
mounted. Paraffin blocks of formalin-fixed tissues were obtained from the 
Department of Surgical  Pathology of the George Washington University 
Medical Center (Washington,  D.C.) and from the University of Alabama 
Medical Center (Birmingham, AL).  Formalin-fixed,  paraffin-embedded 
sections (5 ttm) were deparaflinixed and hydrated with xylenes and a graded 
alcohol series.  Sections were washed in distilled H20 for 5 rain and in PBS 
for 10 rain. Sections were then incubated in 0.3% H202 in methanol for 30 
rain to inactivate  any endogenous peroxidase activity.  The sections were 
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45 rain at room temperature. The slides were processed exactly as above 
except that the sections were exposed to primary antibody for 12 h. 
Results 
Characterization of  Antipeptide Antibodies 
against Amphiregulin 
Peptides  corresponding to  residues  8-26  (peptide  1)  and 
residues 26-44 (peptide 2) of AR were synthesized and used 
to generate antipeptide antibodies.  These regions of AR 
were chosen since they had no significant sequence homol- 
ogy to any known protein (Shoyab et al., 1989). The antisera 
generated from the rabbits were screened for the ability to 
detect the peptide antigen,  native AR and detect AR in 
formalin-fixed cells or tissues as described in Materials and 
Methods.  One  antisera  generated  against peptide  2  and 
designated AR-Ab2 was found to be most effective in the de- 
tection of native AR.  The AR-Ab2  antibodies specifically 
immunoprecipitated secreted AR from the culture medium 
of PMA-treated MCF-7 cells after the cells had been meta- 
bolically labeled with p~S]cysteine and in an ELISA were 
capable of  detecting as little as I ng of purified AR (data not 
shown). None of  the antisera generated showed any cross re- 
activity with EGF or TGFc~ in an ELISA. The ability of an- 
tisera to detect cell-associated AR after fixation with formal- 
dehyde was tested by performing immunocytochemistry  on 
cell lines which are positive or negative for AR mRNA. 
These experiments revealed that one antibody preparation 
directed against peptide 1 and designated AR-Abl could de- 
tect AR in formalin-fixed specimens. The AR-Abl antibodies 
were able to detect ,,,,5 rig of purified AR, and could easily 
detect as little as 40 pg of the peptide antigen in an ELISA 
(data not shown). In immunocytochemical staining of col- 
tared cells, the AR-Abl antibodies were found to stain only 
cells which express the AR mRNA. We have observed that 
there is a corresponding increase in the level of expression 
of  AR mRNA and the intensity of staining using the AR-Abl 
antibodies in  human mammary epithelial cells  following 
transformation with various oncogenes (N.  Normanno, T. 
Saeki, N. Kim, G. R. Johnson and D. S, Salomon, unpub- 
lished work). The AR-Ab2 antibodies also were found to be 
useful for immunocytochemical applications, but reactivity 
under these conditions was less than the staining achieved 
with the AR-Abl antibodies. 
Amphiregulin Is a Mitogen for Geo Cells 
The Geo cell line is derived from a human colon carcinoma 
(Brattain et ai., 1981) and proliferates autonomously under 
serum-free conditions.  To determine if AR is capable of 
stim~ating the growth of Geo cells, the effect of AR on the 
anchorage-dependent growth of  the Geo cell line was studied 
under serum-free conditions. The exogenous addition of ei- 
ther AR or EGF was found to stimulate the proliferation of 
the Geo cells (Fig. 1). Maximal stimulation of growth (•2.8- 
fold over controls) was observed at a concentration of 1-5 nM 
AR, whereas for EGF maximal stimulation of  growth (*3.5- 
fold) was observed at 0.2 nM. The Geo cells were more sen- 
sitive to the exogenous addition of EGF as compared to AR, 
with half-maximal stimulations of growth at 40 and 200 pM 
for EGF and AR, respectively. 
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Figure I. Stimulation of growth of Geo cell line by exogenous  am- 
phiregulin or EGF. Mitogenesis assays were performed in serum- 
free medium as described in Materials and Methods. Data points 
represent the mean + SEM of experiments performed in triplicate 
and the effect of growth factor on growth is expressed relative to 
growth in the absence of growth factor (control). The cells were 
initially plated at a density of 10,000 cells/well and after 4 d control 
wells contained ,'~31,500 cells. 
A mAb against the EGF  Receptor Blocks 
Amphiregulin-induced Mitogenesis 
If the AR-induced mitogenesis involves an interaction be- 
tween AR and the EGF receptor,  it should be possible to 
block this mitogenesis using a mAb directed against the ex- 
tracellular domain of the EGF receptor. This commercially 
available mAb reacts with the extraceUular domain of the 
EGF receptor on all human cells, competes for binding of 
EGF to the EGF receptor on human cells, blocks the biologi- 
cai effects induced by EGF, but does not activate the tyrosine 
ldnase activity of the EGF receptor (Dr. J. Denry Sato, per- 
sonal  communication).  Geo  cells  have  been  previously 
shown to express ~9,000 EGF receptors per cell (Wan et al., 
1988;  Mulder and Brattain, 1989).  As shown in Fig. 2, 10 
nM of the anti-EGF receptor mAb completely blocked the 
stimulation of growth of the Geo cell line induced by 200 pM 
of exogenous AR.  An isotype control mAb  was used to 
confirm that the inhibition induced by the anti-EGF receptor 
mAb was specific.  The presence of the control mAb, by it- 
self, had no significant effect on cell growth (Fig. 2). 
Geo Cells Constitutively Express the Amphiregulin 
mRNA Transcript 
To demonstrate that the Geo cells express AR mRNA under 
serum-free conditions,  PCR  amplification of eDNA  was 
used since this technique is capable of  detecting mRNA tran- 
scripts in small numbers of cells (Rappolee et al., 1989). l"o- 
tal cellular RNA was reverse transcribed using oligo(dT) 
primers to generate double stranded eDNA substrates and 
sense and antisense oligonucleotide primers corresponding 
to positions 510-533  and 738-761  of the AR eDNA (How- 
man et al., 1990), respectively, were used to PCR amplify 
an ,~250-bp region encoding the mature protein. The gener- 
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Figure 2.  Effect of an anti-EGF receptor mAb on amphiregulin- 
induced mitogenesis. Geo cells were grown in serum-free medium 
in the presence  of 0.2  nM  AR containing  either  10 nM  of an 
anti-EGF receptor  mAb or 10 nM of  an isotypr control mAb. After 
4  d,  ceils  were trypsinized and counted.  Data  points  represent 
the mean +  SEM of experiments performed in triplicate. Results 
are expressed relative to the growth of the cells in the absence 
of AR and mAb  (control). The cells were initially plated  at a 
density of 30,000 cells/well and after 4 d control wells contained 
~81,400 cells. 
ated target sequence was then validated by size fractionation 
of the PCR products on an agarose gel. The MDA-MB-453 
and PMA-treated MCF-7 cell lines which have been previ- 
ously demonstrated to be negative and positive for expres- 
sion of the  1.4-kb AR mRNA transcript (Plowman et al., 
1990), respectively, were used to further validate the proce- 
dure. Fig. 3 shows that primer-directed amplification (30 cy- 
cles) of 100 ng of eDNA from Geo (Fig.  3, left lane)  and 
MCF-7 cells treated with 100 ng/ml of PMA for 24 h (Fig. 
3, right lane) yield the diagnostic '~250-bp band specific for 
AR, whereas there was no detectable band produced by PCR 
amplification of the  MDA-MB-453  eDNA  (Fig.  3,  center 
lane).  Further,  digestion of the  ~250-bp  target sequence 
produced  by  PCR  amplification  (Geo  and  PMA-treated 
MCF-7 cells) with the BsmI restriction endonuclease results 
in the generation of two fragments of ",,80- and  '~170-bp 
size, exactly as predicted (data not shown). Thus, the results 
unequivocally demonstrate that Geo cells constitutively ex- 
press the AR mRNA transcript under serum-free conditions. 
Antibodies to Amphiregulin Detect the Protein in 
Geo Cells 
Fig.  4  b  demonstrates  the intense brown immunospecific 
staining of Geo cells which resulted from use of the purified 
AR-Abl  IgG.  Controls  using  the  IgG  purified  from  the 
preimmune serum (Fig. 4 a) or the AR-Abl IgG which had 
been preabsorbed with the peptide antigen (Fig. 4 c) did not 
result in significant staining of the cells. 
Geo Cells Secrete Amphiregulin 
The AR-Ab2 antibodies which are directed against residues 
26-44 of AR were used to ascertain whether the Geo cells 
secrete  AR.  The  cells  were  metabolically  labeled  with 
[~S]cysteine and  after 22  h  the conditioned medium was 
Figure 3. Analysis of AR mRNA expression by Geo cells. Poly(A)  + 
mRNA was converted into eDNA as described in Materials and 
Methods section. PCR amplification O0 cycles) of 100 ng of  eDNA 
derived from each cell line was performed, products fractionated 
in an ethidium bromide-containing Seakem agarose gel and bands 
visualized by UV illumination. The sense and antis,  me primers 
correspond to positions 510-533 and 738-761 of the AR eDNA 
(Plowman et al.,  1990), respectively, and yield a predicted target 
sequence of '~ 250 bp upon PCR amplification, eDNA from Geo 
(le~ lane), MDA-MB-453 (center lane) and MCF-7 ceils after 24 h 
treatment with 100 ng/ml PMA (right lane) were PCR amplified. 
The positions of a Hael~ digest of $X174 are shown to the left 
(in bp). 
collected.  Immunoprecipitations  were performed and  the 
resultant material  was  fractionated under reducing condi- 
tions in a 16 % acrylamide SDS-PAGE gel. Radiolabeled AR 
was immunoprecipitated specifically from conditioned me- 
dium using AR-Ab2 antibodies (Fig.  5,  C-eo, center lane). 
The secreted AR migrated as a broad, diffuse band with a 
molecular weight that ranged from ',,18.5 to 22.5 kD and had 
a median molecular weight of '~,20.7 kD. Immunoprecipita- 
tions performed with the preimmune serum (Fig. 5, Geo, left 
lane) or with the AR-Ab2 serum in the presence of excess 
peptide  antigen  (Fig.  5,  Geo,  right  lane)  confirmed the 
specificity of the immunoprecipitation using the AR-Ab2 an- 
tibodies.  Furthermore,  immunoprecipitations  performed 
using the MDA-MB-453  negative control cell line (Fig.  5, 
MDA-MB-453) also confirmed  the specificity of  the immuno- 
precipitation  of AR  from  Geo-conditioned medium.  AR 
which has  been immunoprecipitated from medium condi- 
tioned by Geo cells and AR from medium conditioned by 
PMA-treatexl MCF-7  cells migrate in  an almost identical 
fashion in SDS-PAGE (data not shown). The migration of  the 
AR as a broad, diffuse band with median molecular weight 
of ,~, 21 kD in SDS-PAGE is characteristic of AR and is most 
likely due to heterogeneous glycosylations and truncation of 
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chemistry, lmmunocytochemistry  was performed using the purified 
AR-Abl IgG directed against residues 8-26 of AR as described in 
the Materials  and Methods section.  The cells were exposed to ei- 
ther 10 gg/ml of preimmune control IgG (a), 10 gg/ml of AR-Abl 
(b), or 10 gg/ml AR-Abl IgG that was preabsorbed with 20 #g/ml 
peptide antigen (c). All cells have been counterstained with Mayer's 
hematoxylin. 
Figure  7.  Immunohistoehemical  detection  of  amphiregulin  in 
normal and malignant human colon using the AR-Abl antibodies. 
Immunohistochemistry  was performed on formalin-fixed, paraffin- 
embedded sections as described in the Materials and Methods sec- 
tion.  Normal colonic mucosa (a-d) is shown after staining with 
preimmune IgG (a and c) or AR-Abl IgG (b and d). The arrows 
in b denote the intense staining observed at the luminal surface of 
the normal mucosa. The luminal surface epithelium of a normal co- 
lon is shown at high magnification in c and d. The large and small 
arrows in d denote examples of intense, uniform nuclear  staining 
and punctate  nuclear  staining  of AR,  respectively. Staining of a 
weft-differentiated (e and f) and poorly differentiated (g) adenocar- 
cinoma of the colon is shown using the AR-Abl IgG. All sections 
have been counterstained  with Mayer's hematoxylin. 
the six NH2-terminal amino acid residues of the AR mole- 
cule (Shoyab et al.,  1988). To confirm that the Geo cells se- 
crete  a  biologically  active  EGF-like  factor,  serum-free 
medium was conditioned by the Geo cells and then tested for 
the ability to support the proliferation of the MCF-10A cell 
line, a mammary epithelial cell line which has an obligatory 
requirement for the exogenous addition of EGF for growth 
(Soule et al., 1990). Geo conditioned medium (diluted 2-20- 
fold with fresh medium) and purified AR were both found 
to support the growth of the MCF-10A cells and thus were 
able to supplant the  growth requirement of these cells for 
EGF (data not shown). 
Proliferation  of Geo Cells Is Inhibited by 
Immunospecific Depletion of  Amphiregulin from the 
ExtraceUular Medium and by an Anti-EGF 
Receptor mAb 
The  inclusion  of the  AR-Abl  or  AR-Ab2  antibodies  was 
found  to  have  no  significant  effect  upon  the  anchorage- 
dependent growth of the Geo cells in serum-free medium, in- 
dicating that these antibodies are incapable of neutralizing 
the biological activity of secreted AR under these conditions. 
These antibodies were also incapable of inhibiting the action 
of exogenously added AR on Geo cells (data not shown). 
Therefore,  to  test the  hypothesis  that  AR is  an autocrine 
growth factor for the Geo ceils a different strategy was used. 
AR  was  immunospecifically  removed  from  serum-free 
medium conditioned by the cells using the purified AR-Ab2 
IgG and then the AR-depleted medium was added back to 
the cells. The cells were allowed to continue growing for an- 
other day and then the culture medium was again depleted 
of AR. It is important to note, as demonstrated in Fig. 5, that 
this  procedure  specifically  removes  AR  from  the  Geo- 
conditioned medium. The consequence of this depletion of 
Figure 5.  Immunoprecipitation  of amphiregulin  secreted by Geo 
cells.  Geo and  MDA-MB-453 cells  were  metabolically  labeled 
with [35S]cysteine  and secreted AR was immunoprecipitated as de- 
scribed in the Materials  and Methods  section. Immunoprecipita- 
tions were performed using preimmune sera (left lanes), AR-Ab2 
sera (center lanes) or AR-Ab2 sera in the presence of excess peptide 
antigen (right lanes). Samples were run under reducing conditions 
in  a  16%  acrylamide  SDS-PAGE gel  and  autoradiographed  at 
-80"C. The arrow on the right denotes the position of AR in the 
gel. The positions and tool wt of  marker proteins in kilodaltons are 
shown at the left. 
AR from the medium was a  39.9%  inhibition of Geo cell 
growth relative to cells which were treated in an identical 
manner using the purified preimmune IgG as  the  control 
(Fig. 6 A). The processing of the conditioned medium using 
the control preimmune IgG and re,  addition of the medium to 
the cells had only a minor growth inhibitory effect ('~20%) 
when compared to cells in which the conditioned medium 
was not processed at all, demonstrating that the processing 
alone did not have a dramatic effect on mitogenic activities 
in the conditioned medium.  These results indicate that the 
AR secreted by Geo cells is biologically active and stimu- 
lates the growth of these cells via an autocrine mechanism. 
To ascertain if the EGF receptor is involved in the auto- 
crine growth of Geo cells, the cells were grown in the pres- 
ence of the anti-EGF receptor mAb under serum-free condi- 
tions. The anti-EGF receptor mAb also inhibited the growth 
of the Geo cells by 50.5% relative to their growth in the ab- 
sence of any mAb (Fig. 6 B). The presence of an isotype con- 
trol mAb had no significant effect on the growth of the cells. 
These results indicate that both secreted AR and the EGF 
receptor are involved in the autocrine growth of these cells. 
Immunolocalization of  Amphiregulin in Normal 
and Malignant Human Colon 
The AR-Abl antibodies were used to detect AR in the normal 
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Figure 6.  Inhibition  of Geo 
cell growth by immunospecific 
depletion  of AR from extra- 
cellular  medium  and  by  an 
anti-EGF  receptor mAb.  (A) 
Inhibition of cell proliferation 
by  irnmunospecific  removal 
of AR from conditioned  me- 
dium.  2 d after initially plat- 
ing  of the  Geo  cells  under 
serum-free  conditions,  the 
conditioned medium was col- 
lected and AR was specifically 
immunoprecipitated using pu- 
rified AR-Ab2 IgG  as described 
in the Materials and Methods 
section. The AR-depleted me- 
dium was then added back to 
the cells and after 24 h,  the 
conditioned medium was pro- 
cessed again. After 24 h, the cells were trypsinized and counted.  The results represent the mean +  SEM of experiments performed in 
triplicate using either the preimmune IgG (control) or the AR-Ab2 IgG. The cells were initially plated at a density of 48,000 cells/well 
and at the end of the experiment control wells contained ~100,500 cells. (B) Inhibition of cell proliferation by an anti-EGF receptor mAb. 
G-co cells were plated into 12-well  plates and grown in serum-free medium containing 10 nM anti-EGF receptor mAb, 10 nM of an isotype 
control mAb or no mAb. After 4 d, the cells were trypsinized  and counted.  Results are expressed relative to the growth of the cells in 
the absence of any mAb and represent the mean 5: SEM of experiments performed in triplicate. The cells were initially plated at a density 
of 30,000 cells/well and after 4 d control wells contained  '~82,200 cells. 
colon from five individuals who were free of any colon dis- 
ease.  Immunohistochemistry was  performed  on paraffin- 
embedded, formalin-fixed sections and the samples were ex- 
amined at various degrees of magnification. In all normal 
specimens, AR was localized only in epithelial cells of the 
colonic mucosa. The brown immunoperoxidase staining re- 
vealed that AR was localized to the surface columnar and 
secretory (goblet) epithelial cells of the luminal surface of 
the mucosa (Fig.  7  b),  and was not detectable in the less 
differentiated, proliferative cells of the crypts. Fig. 7 a shows 
the lack of staining using the control preimmune antibodies 
in  a  companion  section  from the  identical  tissue  region. 
There was a gradient of increasing immunoperoxidase stain- 
ing of AR towards the lumen, with the most intense staining 
observed at the luminal surface. In some of the specimens 
extracellular AR was occasionally detected within the lumen 
of the colon.  At higher magnification, it was clear that the 
AR was localized to both the cytoplasm and the nucleus of 
the surface columnar and secretory cells of the mucosa (Fig. 
7 d). Fig. 7 c shows the staining achieved using the control 
preimmune antibodies in a companion section from the iden- 
tical tissue region. The larger arrows in Fig. 7 d denote the 
intense uniform staining of AR in the nucleus of some cells, 
whereas the smaller arrows denote punctate brown nuclear 
staining of AR that was also observed. In some instances, 
AR appeared to be associated with the plasma membrane of 
the cells. The large oval transparent cytoplasmic inclusions 
seen near the luminal  surface in  Fig.  7  d  are mucin-rich 
secretory granules characteristic of secretory (goblet) cells 
(Colony, 1989). AR was not detectable within these secre- 
tory granules.  Immunohistochemical analysis of the same 
sections using the AR-Ab2 antibodies which recognize a dis- 
tinct region of AR relative to the AR-Abl antibodies yielded 
equivalent results, although with less intense staining (data 
not shown). 
The AR-Abl antibodies were then used to detect and local- 
ize AR in five specimens derived from adenocarcinomas of 
the colon. AR was found in two well, one of two poorly and 
one undifferentiated carcinoma. The AR was localized to the 
carcinoma cells of the tumors. Figure 7 e shows the intense 
immunostaining  of  a  well-differentiated  adenocarcinoma 
using this anti-AR antibody. The subcellular localization of 
AR in the carcinoma cells of the tumors was somewhat het- 
erogeneous within and among specimens. The AR was de- 
tected in either cytoplasm or nucleus of the cells, or in both 
of these subcellular locations. The cytoplasmic localization 
of AR  in  the  cells  of a  well  differentiated  carcinoma  is 
demonstrated in Fig. 7f  The AR appears to be concentrated 
within a cytoplasmic organelle and it is possible that this sub- 
cellular organelle is the Golgi apparatus. Fig.  7 g  demon- 
strates  the  nuclear  localization  of AR  in  the  vacuolated 
nuclei of cells in a poorly differentiated colonic carcinoma. 
In some instances, extracellular AR was detectable in the lu- 
men of the glands of the carcinomas.  Controls performed 
using preimmune antibodies confirmed the specificity of the 
immunostaining  observed  in  these  specimens  (data  not 
shown). 
Discussion 
Evidence That the EGF Receptor Mediates the 
Mitogenesis Elicited by Amphiregulin 
Geo cells are classified as a differentiated colonic carcinoma 
cell line relative to other colon carcinoma cell lines based 
upon a number of criteria (Wan et al.,  1988;  Mulder and 
Brattain, 1989). In general, the more differentiated cell lines 
express  ~8-20  x  103  EGF  receptors  per  cell  and  are 
growth  stimulated  by  the  exogenous  addition  of  EGF, 
whereas poorly differentiated colon carcinoma cell lines ex- 
press <3  ￿  103 receptors per cell and do not respond to the 
exogenous addition of EGF (Wan et al.,  1988; Mulder and 
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AR stimulates  the growth of Geo cells, it is not as potent as 
EGF.  AR is known to compete for binding  of lzSI-EGF to 
EGF receptors on human A431 cells, but is not as effective 
as EGF (Shoyab et al., 1989). Conversely, AR was as effec- 
tive as EGF at competing for binding  of lzSI-EGF to EGF 
receptors  on  mouse  AKR-2B  cells  (Cook et  al.,  1991). 
Nevertheless,  there is no direct evidence to date to indicate 
that the EGF receptor is the receptor through which the bio- 
logical  action of AR is mediated.  Our observation that  a 
rnAb to the extracellular  domain of the EGF receptor com- 
pletely blocks the mitogenesis induced by AR,  taken to- 
gether with the fact that AR can compete for binding of ~2sI- 
EGF to the EGF receptor provides strong evidence that the 
EGF receptor is the cell surface molecule through which AR 
acts in Geo cells. Further,  the observations that the addition 
of exogenous AR to A431 cells leads to phosphorylation of 
the EGF receptor (M. Shoyab, unpublished work) and that 
AR can  support the growth of MCF-10A  cells,  an EGF- 
dependent cell line, provide additional evidence that AR can 
act through  the EGF  receptor.  The fact that  AR-induced 
mitogenesis can be completely blocked by a mAb to the EGF 
receptor suggests that there is not an additional  cell surface 
receptor on Geo cells which can transduce a biological sig- 
nal in response to AR. 
Amphiregulin As an Autocrine Growth Stimulator 
The Geo colon carcinoma cells constitutively express the AR 
mRNA, secrete AR protein into the extracellular  medium, 
are growth stimulated  by the exogenous addition of AR and 
are partially growth inhibited by depletion of AR from its ex- 
tracellular medium and by an anti-EGF receptor rnAb. This 
clearly demonstrates that AR is an autocrine growth stimula- 
tor for Geo cells.  Taken together with the observation that 
an anti-EGF receptor mAb blocks the mitogenic stimulation 
invoked by AR, the findings  suggest that AR can function 
through  an  extracellular  autocrine  loop that  involves  the 
EGF receptor. Since we were only able to partially inhibit 
the growth of the Geo cells, other secreted growth factors 
may stimulate  the proliferation of these cells via autocrine 
mechanisms.  It has been suggested  that autocrine growth 
factors may play a  role in malignant  transformation  and 
growth of cancer cells (Sporn and Todaro, 1980; Sporn and 
Roberts,  1985; Lang and Burgess,  1990). There is consider- 
able evidence which indicates that TGFot may function as an 
autocrine growth stimulator for many types of cancer cells 
(reviewed  in Salomon et al.,  1990) including  colon carci- 
noma cells (Wan et al.,  1988; Murthy et al.,  1989; Mulder 
and Brattain,  1989). Recently, Sizeland and Burgess (1991) 
have demonstrated that TGFo~ is one of two autocrine growth 
factors required for the autonomous growth of the LIM 1215 
colon carcinoma cell line. With the recent discovery of other 
EGF-related molecules such as AR (Shoyab et al.,  1988), 
cripto (Ciccodicola et al., 1989), and heparin-binding  EGF- 
like growth factor (Higashiyama et al., 1991), it is becoming 
clear that the EGF receptor could potentially function  as a 
common  receptor  for  multiple  autocrine  growth  factors. 
Ciardiello  and co-workers 0991b) found that a majority of 
primary and metastatic colorectal carcinomas  express  the 
mRNA for AR and cripto, suggesting that these molecules 
may be involved in the pathogenesis and/or progression of 
this disease.  While there is no evidence that the cripto pro- 
tein is secreted from cells or that it binds to the EGF recep- 
tor, expression of the cripto eDNA has been shown to trans- 
form cells (Ciccodicola et al., 1989; Ciardiello et al., 1991a). 
Our work demonstrates that AR is another EGF-like growth 
regulator which can function  in an autocrine mode. 
lmmunocytochemical Localization of  Amphiregulin in 
Normal and Malignant Colon 
Normal colonic epithelial cells arise, proliferate  and mature 
within the crypts, and migrate to the mucosal surface where 
they are eventually shed (Wright,  1989; Colony, 1989). Co- 
lonic epithelial  cell turnover time is estimated to be 4-8 d 
in humans (Lipkin and Deschner, 1976). The surface colum- 
nar and secretory (goble0 cells of the mucosal surface are 
terminally  differentiated,  non-proliferative  cells  (Wright, 
1989; Colony,  1989). Our finding that AR was exclusively 
localized to these cells and not detectable in the proliferative 
cells of the crypts,  suggests  that  AR is not an autocrine 
growth stimulator for normal colonic epithelial cells in vivo. 
The EGF receptor has been detected in normal human (Mar- 
kowitz et al., 1990) and rat colonic epithelium  (Koyama and 
Podolsky, 1989). In fact, normal rat crypt cell proliferation 
is stimulated  by EGF in vivo (Goodlad et al., 1987; Reeves 
et al., 1991). Further,  the number of EGF receptors is con- 
stant throughout the crypt-villus continuum in rat intestine 
(Koyama and Podolsky,  1989). In some instances,  we were 
able to detect extracellular AR, indicating that the epithelial 
cells of the normal colonic mucosa are capable of secreting 
AR. Therefore, if  one assumes that the biological role of AR 
in the normal colon is one of growth regulation,  it is possible 
that AR is secreted by cells of the luminal  colonic surface 
and acts in a paracrinr  fashion to stimulate  or control the 
growth of proliferative  crypt cells,  As cells leave the crypt 
and are no longer proliferative,  AR may be expressed and act 
to stimulate the growth of cells in the crypt, thus generating 
a  tightly  orchestrated  process of mucosal  renewal.  This 
mechanism  of epithelial  cell turnover may be preferable to 
having crypt cells control their own growth through  auto- 
trine mechanisms,  since autonomous growth could increase 
the likelihood of aberrant or uncontrolled crypt cell growth. 
Interestingly, the amount of the TGFc~ mRNA transcript was 
higher in differentiated villus cells than in mitotically active 
crypt epithelial cells of rat intestine,  whereas TGF/$ mRNA 
levels were higher in crypt cells than in villus cells (Koyama 
and Podolsky, 1989). These authors suggest that these TGFs 
may be involved in the balance between proliferation  and 
differentiation of these cells through autocrine and paracrine 
mechanisms.  Unlike normal colon, one can speculate that in 
colonic adenocarcinomas, AR might function principally  as 
an autocrine growth factor in which the malignant cells have 
the capacity to secrete, as well as respond to AR. 
AR contains two Arg-Lys-Lys-Lys sequences positioned at 
residues 26-29 and 40-43 (Shoyab et al.,  1989).  These se- 
quences suggest that AR may be targeted to and translocated 
into the nucleus of  cells (Roberts,  1989). We have previously 
found that endogenous AR is predominantly localized to the 
nucleus of  both normal ovarian surface epithelial and ovarian 
carcinoma cells in vitro, suggesting that AR plays some bio- 
logical role in the nucleus of cells (Johnson et al., 1991). Our 
finding that AR can be detected in the nucleus of colonic epi- 
thelial  cells in  vivo using antipeptide antibodies  directed 
against  residues 8-26 of AR substantiates  this possibility. 
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quence  homology  to any  known protein  (Shoyab  et  al., 
1988).  We  consistently  detected  AR in the  nucleus and 
cytoplasm of the terminally differentiated cells of the normal 
mucosa. These cells are not mitotically active and it is not 
clear what biological role AR plays in the nucleus of these 
cells. This observation suggests that AR could play a role in 
the differentiation of the cells through a direct effect in the 
nucleus,  although  there  is currently  no evidence that AR 
plays any direct role in differentiation.  In the colonic carci- 
nomas, AR was also often detected in the nucleus of the cells. 
In some cells of the carcinomas it was exclusively localized 
in the cytoplasm of the cells, whereas in some instances it 
was localized just in the nucleus or in both subcellular loca- 
tions. It is difficult to place any significance  upon this obser- 
vation without knowing what function AR serves in the nu- 
cleus of cells.  There  is evidence that other growth factors 
have nuclear sites of action (Burwen and Jones, 1987). The 
addition of exogenous basic fibroblast growth factor to en- 
dothelial cells leads to the accumulation of the growth factor 
in the nucleolus and transcripton of ribosomal genes during 
the G0--GI  transition  (Bouche et al.,  1987).  Renko et al. 
0990)  demonstrated  that  in  cells  which  produce  basic 
fibroblast  growth  factor  the high molecular weight forms 
were localized in the nucleus, whereas the low molecular 
weight (18 kD) form was found primarily in the cytoplasm. 
A  fibroblast  growth  factor-related  protein,  the  int-2  on- 
coprotein, has been detected in the nucleus of cells (Acland 
et al.,  1990).  Attachment  of a nuclear-targeting  sequence 
from yeast histone  2B  to  a  truncated  defective  heparin- 
binding growth factor-1 (acidic fibroblast growth factor) mu- 
tant results in the recovery of its mitogenic activity (Imamura 
et al.,  1990). It is important to note that hepadn binding- 
EGF-like growth factor contains one of the putative nuclear 
targeting sequences found in AR (I-Iigashiyama et al., 1991), 
suggesting that AR may not be the only EGF-related growth 
regulator which is targeted to the nucleus. In summary, the 
finding that AR can be localized to the nucleus of cells in 
vivo strongly  suggests that AR performs some biological 
function in the nucleus of cells. Thus, it will be important 
to determine what this function is to more fully understand 
the role that AR plays in normal and pathological  biological 
processes. 
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